Want to join the conversation?
In 4Q16, $HIBB repurchased 99,000 shares of common stock for a total cost of $3.4MM. The company's Board of Directors approved a new authorization of $300MM in Nov. 2015 and the total authorization was available for future stock repurchases as of Jan. 30, 2016. Cash and cash equivalents at 4Q16-end was $32.3MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.